Medicine
Ethacrynate 50 mg/50 mL powder for injection
Ethacrynate 50 mg/50 mL powder for injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in a tightly closed container between 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Ethacrynate
- Brand
- Sold under the generic name
- Strength
- 50 mg/50 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Manufacturers
- Leading PharmaPar Health
- Origin register
- US FDA, United States
- Storage
- Store in a tightly closed container between 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 July 2015
- Identifiers
- RxCUI 617325DailyMed set ID 3313ed5d-7991-408f-872b-d5a701aa6d83, e24e7440-a958-6fd0-6bfe-1bd29e638657NDC 42023-157, 69315-701Application ANDA205473, ANDA208663
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 50 mL in 1 vial, single-dose | 69315-701-50 | Leading Pharma | 9 January 2026 |
| 1 vial in 1 carton / 50 mL in 1 vial | 42023-157-01 | Par Health | 30 July 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 January 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Ethacrynate is a loop diuretic indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. It is available as powder for injection for intravenous use. MedsAcross supplies Ethacrynate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EthacrynateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ETHACRYNATE SODIUM prescribing information (Par Health) · U.S. National Library of Medicine, DailyMed
Need Ethacrynate 50 mg/50 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.